Significant Ownership of JOHNSON & JOHNSON
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for JOHNSON & JOHNSON focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Signature and title
- /s/ Marc Larkins - Marc Larkins/Secretary
- Location
- New Brunswick, NJ
Large-stake snapshot
1 signal
Manager
2 identity fields
Follow Filing Activity
Follow JOHNSON & JOHNSON and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from JOHNSON & JOHNSON
Significant Ownership of JOHNSON & JOHNSON
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CVRX | CVRx, Inc. | Common Stock, $0.01 par value | 15% | $28,578,928 | 4,024,861 | JOHNSON & JOHNSON | 31 Dec 2025 | ||
| RAPP | Rapport Therapeutics, Inc. | Common Stock, $0.001 par value | 4.9% | $53,000,690 | 1,784,517 | JOHNSON & JOHNSON | 30 Sep 2025 | ||
| RLYB | Rallybio Corporation | Common Stock, $0.0001 par value | 2.9% | $88,683 | 152,901 | Johnson & Johnson | 31 Mar 2026 |
Schedules 13D/G Reported by JOHNSON & JOHNSON:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.